2. INTRODUCTION Kidney transplant or renal transplant is the
organ transplant of a kidney into a patient with end stage renal
disease (ESRD) 3. CLASSIFICATION DESEASED DONOR (CADAVERIC) LIVING
DONOR1. GENETICALLY RELATED LIVING RELATED)2. NON RELATED (LIVING
UNRELATED) 4. INDICATION ESRD GFR less than 15ml/L MALIGNANCY
HYPERTENSION DIABETES MELLITUS GENETIC DISEASES- polycystic kidney
diseases METABOLIC DISORDERS AUTO IMMUNE CONDITIONS- lupus
,goodpastures syndrome CRF 5. CONTRAINDICATIONS CARDIAC
ANDPULMONARY INSUFFICIENCY HEPATIC DISEASES CONCURRENT TOBACCO USE
AND MORBIDOBESITY PUTS THE PATIENT AT RISK FORSURGERY. SUBSTANCE
ABUSE HIV 6. LIVING DONORS EVALUATE DONORS ON PHYSICAL,MEDICALAND
PSYCHOLOGICAL GROUNDS. ASSURE THE PATIENT THAT THERE WILL BENO LONG
TERM HARM TO DONOR. IN SOME CASES MALE LIVING DONOR MAYDEVELOP A
HYDROCELE ON THE SCROTUMON THE SIDE OF NEPHRECTOMY. LIVE DONOR
PROCEDURE ARE MOSTLYLAPROSCOPIC,HENCE LESS PAINFULL,LESSSCARRING
AND FASTER RECOVERY. 7. DESEASED DONORS BRAIN DEAD (BD) DONORS
DONATION AFTER CARDIAC DEATH BRAIN DEAD OR BEATING HEART donors are
considered dead but the pumping heart continues to perfuse the
other organs. DONATION AFTER CARDIAC DEATH are elective donation of
organ by patient himself or the relatives to withdraw life support
as they have slim chances of survival. 8. COMPATIBILITY THE PATIENT
HAS TO BE ABO COMPATIBLE THE RECEPIENT SHOULD SHARE AS MANYAS HLA
ANTIGENS AND MINOR ANTIGENS ASPOSSIBLE. IMMUNOSUPRESSENT DRUGS ARE
GIVEN TOPREVENT ANTI BODY REACTIONS PERFORM ANTI BODY TEST ON
POTENTIALRECEPIENT. 9. POST OPERATION TIME- 3 HRS APPROX DONOR
KIDNEY WILL BE PLACED IN THELOWER ABDOMEN ARTERIES,VIENS FROM THE
RECIPIENTSBODY IS CONNECTED TO NEW KIDNEY FINAL STEP IIS TO CONNECT
THE URETERTO NEW KIDNEY NEW KIDNEY STARTS FUNCTIONINGIMMEDIATELY,
LIVING KIDNEY TAKE 3-5DAYSAND CADEVERIC KIDNEY TAKE UPTO 7-15DAYS
10. Contd.. DIURETICS AND IMMUNOSUPRESSANTS AREADMINISTERED FOR
EFFECTIVEFUNCTIONING OF NEW KIDNEY. MONTIOR KFT,CBC. BIOPSY. 11.
POST OPERATIVE DIET AVOID GRAPES POMEGRANATE AND GREENTEA PRODUCTS
MONITOR FOR KIDNEY REJECTION. 12. COMPLICATION TRANSPLANT
RREJECTION INFECTION AND SEPSIS POST TRANSPLANT LYMPH
PROLIFERATIVEDISORDER ELECTROLYTE IMBALANCES IATRAGENIC SIDE
EFFECTS 13. PROGNOSIS KIDNEY TRANSPLANTATION IS A LIFEEXTENDING
PROCEDURE.A PATIENT MAYLIVE UPTO 15YRS LONGER WITH A
KIDNEYTRANSPLANT THAN IF KEPT ON A DIALYSIS. PATIENTS WILL HAVE
MORE ENERGY,A LESRESTRICTED DIET,AND FEWERCOMPLICATIONS WITH A
KIDNEYTRANSPLANT. 14. BIBLIOGRAPHY Phipps medical and surgical
nursing health andillness perspective. Brunner and suddarths
textbook of medical andsurgical nursing Google .com 15. THANK
YOU
